People with certain conditions, such as severe kidney disease or allergies to B12 components, should discuss suitability with their provider
Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Valeria Marulanda, our clinical lead, frames the comparison this way: NAD+ restores cellular energy and helps patients feel better faster, and growth hormone peptides like CJC-1295/Ipamorelin support the structural anti-aging goals patients often associate with Sermorelin. That framing holds across virtually every patient who presents asking which direction to take
This timing is strategic because it aligns with your bodys natural spike in growth hormone release during deep sleep, allowing the peptides to work more effectively
Safety & Disclaimers: This product is intended for laboratory, research, or compounding use only
